American Thoracic Society Provides Tips for Hospitals to Manage IV Fluid Supply Amid Shortage
By Lori Solomon HealthDay Reporter
TUESDAY, Oct. 15, 2024 -- The American Thoracic Society is providing tips to help hospitals mitigate impacts on intravenous (IV) fluid supply resulting from manufacturing disruptions due to recent hurricanes.
W. Graham Carlos, M.D., and colleagues provide guidance on how health care systems facing shortages of these fluids may conserve fluids and address the shortages.
Tips include converting patients to oral rehydration, oral medications, and oral antibiotics, as appropriate; reconfiguring electronic health records to guide appropriate prescribing and routine reassessment of the need for IV fluid orders; implementing specific breakpoint criteria for utilization of IV electrolytes and preferentially use oral repletion of electrolytes; limiting utilization of parenteral nutrition; and considering delay of elective surgeries. Additionally, the authors suggest using a “just-in-time” approach to eliminate waste with prespike fluids, balancing having enough against wasting fluids that need to be discarded due to time in warmer, and using smaller bag sizes for low-rate continuous infusions when possible.
“IV fluids are lifesaving for many people who present in shock due to trauma, infection, or bleeding. We need to work together as a nation to ensure that they have the IV fluids if/when they are needed,” Carlos said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-16 06:00
Read more
- ACAAI: 2013 to 2023 Saw Rise in Pediatric Psych Referrals Tied to Food Allergies
- What You Need to Know About FluMist, the Nasal Flu Vaccine
- Younger Patients More Affected by Neurologic Manifestations of Long COVID
- Malaria Developing Resistance to Drug That Saves Children's Lives
- Scientists Successfully Reverse Liver Fibrosis in Mice
- Policies About Late-Career Physicians Are Considered Successful
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions